Table 1.

Demographics and clinical descriptors for the entire study cohort

All patients‘Early BSC decision’ group‘Further investigations’ group
Age, years, mean (SD)79.1 (10.1)79.7 (11.1)78.1 (8.51)
WHO performance status, n (%):
0
1
2
3
4

0 (0)
6 (8)
9 (12)
47 (61)
15 (19)

0 (0)
2 (4)
4 (9)
27 (59)
13 (28)

0 (0)
4 (13)
5 (16)
20 (65)
2 (6)
Clinical frailty score, n (%):
1
2
3
4
5
6
7
8
9

0 (0)
0 (0)
0 (0)
1 (1)
5 (6)
31 (40)
20 (26)
2 (3)
1 (1)

0 (0)
0 (0)
0 (0)
1 (2)
2 (4)
21 (46)
11 (24)
2 (4)
1 (2)

0 (0)
0 (0)
0 (0)
0 (0)
3 (10)
10 (32)
9 (29)
0 (0)
0 (0)
score not available17 (22)8 (17)9 (29)
TNM stage, 8th edition, n (%):
I
II
III
IV

5 (6)
3 (4)
17 (22)
52 (68)

1 (2)
2 (4)
12 (26)
31 (67)

4 (13)
1 (3)
5 (16)
21 (68)
Initial decision maker, n (%):
consultant55 (71)33 (72)32 (71)
senior fellow17 (21)9 (19)8 (26)
registrar5 (6)4 (9)1 (3)
Seen by lung CNS, n (%)69 (90)39 (85)30 (97)
Seen by specialist palliative care, n (%)42 (55)22 (48)20 (65)
  • CNS = cancer nurse specialist; SD = standard deviation; TNM = tumour, node and metastasis; WHO = World Health Organization.